These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34776245)

  • 1. Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay.
    Isles N; Badman SG; Ballard S; Zhang B; Howden BP; Guy R; Williamson DA
    Pathology; 2022 Feb; 54(1):120-122. PubMed ID: 34776245
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the analytical and clinical performance of two RT-PCR based point-of-care tests; Cepheid Xpert® Xpress CoV-2/Flu/RSV plus and SD BioSensor STANDARD™ M10 Flu/RSV/SARS-CoV-2.
    Jensen CB; Schneider UV; Madsen TV; Nielsen XC; Ma CMG; Severinsen JK; Hoegh AM; Botnen AB; Trebbien R; Lisby JG
    J Clin Virol; 2024 Jun; 172():105674. PubMed ID: 38643722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test.
    Wolters F; Grünberg M; Huber M; Kessler HH; Prüller F; Saleh L; Fébreau C; Rahamat-Langendoen J; Thibault V; Melchers WJG
    J Med Virol; 2021 Oct; 93(10):5798-5804. PubMed ID: 34050951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
    Mostafa HH; Carroll KC; Hicken R; Berry GJ; Manji R; Smith E; Rakeman JL; Fowler RC; Leelawong M; Butler-Wu SM; Quintero D; Umali-Wilcox M; Kwiatkowski RW; Persing DH; Weir F; Loeffelholz MJ
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of Savanna RVP4 (QuidelOrtho) for the detection of Influenza A virus, RSV, and SARS-CoV-2.
    Köse B; Schaumburg F
    Microbiol Spectr; 2024 Aug; 12(8):e0115324. PubMed ID: 38990032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens.
    Leung EC; Chow VC; Lee MK; Tang KP; Li DK; Lai RW
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33436456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
    Kim SH; AlMutawa F
    Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study evaluating one multiplex RT-PCR assay to detect SARS-CoV-2, influenza A/B, and respiratory syncytia virus using the LabTurbo AIO open platform: epidemiological features, automated sample-to-result, and high-throughput testing.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Yang YS; Chen CW; Hsieh SS; Tang SH; Perng CL; Chang FY; Hung KS; Chen ES; Yang MH; Shang HS
    Aging (Albany NY); 2021 Dec; 13(23):24931-24942. PubMed ID: 34897035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of Cepheid Xpert Xpress Flu/RSV assay for use with gargle samples, sputa and endotracheal secretions.
    Bennett S; MacLean A; Gunson R
    J Hosp Infect; 2019 Jan; 101(1):114-115. PubMed ID: 30026005
    [No Abstract]   [Full Text] [Related]  

  • 10. Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment.
    Shihabuddin BS; Faron ML; Relich RF; Van Heukelom P; Mayne D; Staat MA; Selvarangan R; Hueschen LA; Wolk DM; House S; Harnett G; McGann K; Steele MT; Romero JR; Arms J; Lander O; Loeffelholz M; Strouts F; Cohen D
    Diagn Microbiol Infect Dis; 2022 Oct; 104(2):115764. PubMed ID: 35917666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.
    Cohen DM; Kline J; May LS; Harnett GE; Gibson J; Liang SY; Rafique Z; Rodriguez CA; McGann KM; Gaydos CA; Mayne D; Phillips D; Cohen J
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraction-Free Methods for the Detection of SARS-CoV-2 by Reverse Transcription-PCR: a Comparison with the Cepheid Xpert Xpress SARS-CoV-2 Assay across Two Medical Centers.
    Cameron A; Pecora ND; Pettengill MA
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33184055
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Chiu SK; Wang YH; Liao SJ; Li SY; Hsieh SS; Tsai SH; Perng CL; Yang JR; Liu MT; Chang FY; Shang HS
    Emerg Microbes Infect; 2021 Dec; 10(1):161-166. PubMed ID: 33410371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput.
    Phan T; Tran NYK; Gottlieb T; Siarakas S; McKew G
    Pathology; 2022 Jun; 54(4):466-471. PubMed ID: 35461715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Cepheid Xpert Xpress Flu/RSV Assay to in-house Flu/RSV triplex real-time RT-PCR for rapid molecular detection of Influenza A, Influenza B and Respiratory Syncytial Virus in respiratory specimens.
    Ho YII; Wong AH; Lai RWM
    J Med Microbiol; 2018 Nov; 67(11):1576-1580. PubMed ID: 30207514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses.
    Davies S; Boller E; Chase J; Beaubrun A; Miller C; Jensen I
    J Med Econ; 2024; 27(1):430-441. PubMed ID: 38328858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of Xpert Xpress Flu/RSV for the Detection of Influenza and Respiratory Syncytial Viruses.
    Liu YL; Xie TA; Lin GL; Deng W; Lin QR; Pan ZY; Fan SJ; Li ZX; Ouyang S; Zhu GD; Ji TX; Wu LJ; Xia Y; Guo XG
    Jpn J Infect Dis; 2022 Mar; 75(2):183-191. PubMed ID: 34053954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Xpert Flu/RSV XC and Xpress Flu/RSV Assays.
    Popowitch EB; Miller MB
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
    Serei VD; Cristelli R; Joho K; Salaru G; Kirn T; Carayannopoulous MO; Uprety P
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115208. PubMed ID: 33545455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.